Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.65 |
| ▸ | LMNA | P02545 | 1/20 | 0.65 |
| ▸ | TP53 | P04637 | 1/20 | 0.65 |
| ▸ | TSHR | P16473 | 1/20 | 0.65 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.65 |
| ▸ | CNR2 | P34972 | 1/20 | 0.52 |
| ▸ | ATM | Q13315 | 1/20 | 0.46 |
| ▸ | TYR | P14679 | 1/20 | 0.44 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.39 |
| ▸ | APP | P05067 | 4/20 | 0.38 |
| ▸ | RELA | Q04206 | 2/20 | 0.36 |
| ▸ | APLNR | P35414 | 1/20 | 0.36 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7527708 | 1.00 | CYP3A4 (0.65) | CYP3A4LMNATP53TSHRKDM4E | |
| SCHEMBL9461723 | 1.00 | CYP3A4 (0.65) | CYP3A4LMNATP53TSHRKDM4E | |
| SCHEMBL29982274 | 0.90 | CYP3A4 (0.56) | CYP3A4LMNATP53TSHRKDM4E | |
| SCHEMBL272755 | 0.87 | NFE2L2 (0.56) | CYP3A4LMNATP53TSHRKDM4E | |
| SCHEMBL272756 | 0.87 | NFE2L2 (0.56) | CYP3A4LMNATP53TSHRKDM4E | |
| SCHEMBL840235 | 0.87 | NFE2L2 (0.56) | CYP3A4LMNATP53TSHRKDM4E | |
| SCHEMBL1394423 | 0.85 | ALDH1A1 (0.52) | CYP3A4LMNATP53TSHRKDM4E | |
| SCHEMBL16234246 | 0.85 | CYP3A4 (0.52) | CYP3A4LMNATP53TSHRKDM4E | |
| SCHEMBL555296 | 0.85 | APP (0.59) | CYP3A4LMNATP53TSHRKDM4E | |
| SCHEMBL597516 | 0.85 | APP (0.59) | CYP3A4LMNATP53TSHRKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 309 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240307332-A1 | COMPOSITIONS AND METHODS FOR MODULATING HEXIM1 EXPRESSION | UNIV CASE WESTERN RESERVE (US) | 2024-09-19 | — | — | US | claimed |
| CN-118472393-A | Sodium ion battery electrolyte, preparation method thereof, sodium ion battery and power utilization device | 江苏天合储能有限公司 | 2024-08-09 | — | — | CN | claimed |
| US-11833124-B2 | Compositions and methods for modulating HEXIM1 expression | CASE WESTERN RESERVE UNIVERSITY (US) | 2023-12-05 | — | — | US | claimed |
| US-20220355285-A1 | CATALYST FOR ALKYLENE OXIDE ADDITION REACTION AND APPLICATION THEREOF | CHINA PETROLEUM & CHEMICAL CORPORATION (CN) | 2022-11-10 | — | — | US | claimed |
| EP-4035772-A1 | CATALYST FOR ALKYLENE OXIDE ADDITION REACTION AND APPLICATION THEREOF | China Petroleum & Chemical Corporation (CN) | 2022-08-03 | — | — | EP | claimed |
| US-20210212969-A1 | COMPOSITIONS AND METHODS FOR MODULATING HEXIM1 EXPRESSION | CLEVELAND STATE UNIVERSITY | 2021-07-15 | — | — | US | claimed |
| WO-2021057835-A1 | CATALYST FOR ALKYLENE OXIDE ADDITION REACTION AND APPLICATION THEREOF | 中国石油化工股份有限公司 | 2021-04-01 | — | — | WO | claimed |
| CN-112079886-A | Method for improving purity of xylose and arabinose by chromatographic separation | 甘肃赫原生物制品有限公司 | 2020-12-15 | — | — | CN | claimed |
| CN-106463706-B | Method for manufacturing electrode | 宇部兴产株式会社 | 2019-06-18 | — | — | CN | claimed |
| CN-106165164-B | Method for manufacturing electrode | 宇部兴产株式会社 | 2019-01-22 | — | — | CN | claimed |
| WO-2009058373-A2 | HALO-FUNCTIONAL SILANE, PROCESS FOR ITS PREPARATION, RUBBER COMPOSITION CONTAINING SAME AND ARTICLES MANUFACTURED THEREFROM | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2009-05-07 | — | — | WO | claimed |
| US-20090111923-A1 | Halo-functional silane, process for its preparation, rubber composition containing same and articles manufactured therefrom | MOMENTIVE PERFORMANCE MATERIALS INC. | 2009-04-30 | — | — | US | claimed |
| US-7368584-B2 | Mercapto-functional silane | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2008-05-06 | — | — | US | claimed |
| WO-2008021308-A2 | MERCAPTO-FUNCTIONAL SILANE COMPOSITIONS HAVING REDUCED VOC LEVELS | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2008-02-21 | — | — | WO | claimed |
| US-20080039645-A1 | Mercapto-functional silane | GENERAL ELECTRIC COMPANY (US) | 2008-02-14 | — | — | US | claimed |
| US-7138537-B2 | Coupling agents for mineral-filled elastomer compositions | GENERAL ELECTRIC COMPANY (US) | 2006-11-21 | — | — | US | claimed |
| US-20060217474-A1 | Coupling agents for mineral-filled elastomer compositions | CRUSE RICHARD W | 2006-09-28 | — | — | US | claimed |
| EP-1613636-A1 | COUPLING AGENTS FOR MINERAL-FILLED ELASTOMER COMPOSITIONS | GENERAL ELECTRIC COMPANY (US) | 2006-01-11 | — | — | EP | claimed |
| WO-2004094437-A1 | COUPLING AGENTS FOR MINERAL-FILLED ELASTOMER COMPOSITIONS | GENERAL ELECTRIC COMPANY (US) | 2004-11-04 | — | — | WO | claimed |
| US-20040198881-A1 | Coupling agents for mineral-filled elastomer compositions | CROMPTON CORPORATION | 2004-10-07 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210212969-A1 | COMPOSITIONS AND METHODS FOR MODULATING HEXIM1 EXPRESSION | HK1, HKDC1, HEXB | CYP3A4 3476/4885LMNA 3847/4885TP53 2463/4885 |
| US-11833124-B2 | Compositions and methods for modulating HEXIM1 expression | HK1, HKDC1, HEXB | CYP3A4 3476/4885LMNA 3847/4885TP53 2463/4885 |
| US-20240307332-A1 | COMPOSITIONS AND METHODS FOR MODULATING HEXIM1 EXPRESSION | HK1, HKDC1, HEXB | CYP3A4 3476/4885LMNA 3847/4885TP53 2463/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.